Greg Ball

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

Francesco Onida, Hagop M. Kantarjian, Terry L. Smith et al. · Blood · 2002 · 386 citations · Full text

Medicine, Hematology, Oncology +15

A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis

Kim Papp, David M. Pariser, Mary Catlin et al. · British Journal of Dermatology · 2015 · 116 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Characteristics and outcome of patients with Philadelphia chromosome negative, <i>bcr</i>/<i>abl</i> negative chronic myelogenous leukemia

Francesco Onida, Greg Ball, Hagop M. Kantarjian et al. · Cancer · 2002 · 101 citations · Full text

Medicine, Hematology, Oncology +15

Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus

Vivian Fonseca, Ele Ferrannini, John Wilding et al. · Journal of Diabetes and its Complications · 2012 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +11

The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.

Simona Gatto, Barbara Scappini, Lan Pham et al. · PubMed · 2003 · 77 citations

Medicine, Oncology, Pharmacology +15